Tuesday, June 21, 2016
- 12:30pm-2:00pm
-
Levodopa-responsive hereditary spastic paraplegia, SPG35, due to FA2H mutations in siblings
Rare genetic and metabolic diseases · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Lewy body extracts from Parkinson’s disease brains as models for high-throughput screens of neurotoxicity and α-synuclein spreading from cell-to-cell
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Localization and functional study of synaptic vesicle protein synaptogyrin-3 (SYNGR3) on dopaminergic neuronal system
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Long term recordings of subthalamic ocillatory activity in patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Long-duration response to levodopa in Parkinson’s disease is independent of disease duration: A prospective study on de novo patients in Ghana
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Longitudinal cerebrospinal fluid biomarkers in early Parkinson’s disease and healthy controls
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Longitudinal evaluation of motor and non motor symptoms among LRRK2 risk variants
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Longitudinal follow-up of the association of tic disorders with poor academic performance
Tics/Stereotypies · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson’s disease
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 48
- Next Page»